Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Arad, G., Levy, R., Hillman, D., & Kaempfer, R. (2000). Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nature Medicine, 6(4), 414–421.

Authors 4
  1. Gila Arad (first)
  2. Revital Levy (additional)
  3. Dalia Hillman (additional)
  4. Raymond Kaempfer (additional)
References 46 Referenced 137
  1. Herman, A., Kappler, J.W., Marrack, P. & Pullen, A.M. Superantigens: mechanisms of T-cell stimulation and role in immune responses . Ann. Rev. Immunol. 9, 745– 772 (1991). (10.1146/annurev.iy.09.040191.003525) / Ann. Rev. Immunol. by A Herman (1991)
  2. Schlievert, P.M. Role of superantigens in human disease. J. Infect. Dis. 167, 997–1002 (1993). (10.1093/infdis/167.5.997) / J. Infect. Dis. by PM Schlievert (1993)
  3. Murray, D.L., Ohlendorf, D.H. & Schlievert, P.M. Staphylococcal and streptococcal superantigens: their role in human diseases. Am. Soc. Microbiol. News 61 , 229–235 (1995). / Am. Soc. Microbiol. News by DL Murray (1995)
  4. Bohach, G. A., Fast, D. J., Nelson, R. D. & Schlievert, P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17, 251–272 (1990). (10.3109/10408419009105728) / Crit. Rev. Microbiol. by GA Bohach (1990)
  5. Marrack, P. & Kappler, J. The staphylococcal enterotoxins and their relatives. Science 248, 705– 711 (1990). (10.1126/science.2185544) / Science by P Marrack (1990)
  6. Scholl, P. et al. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 86, 4210–4214 (1989). (10.1073/pnas.86.11.4210) / Proc. Natl. Acad. Sci. USA by P Scholl (1989)
  7. Fraser, J.D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339, 221–223 ( 1989). (10.1038/339221a0) / Nature by JD Fraser (1989)
  8. Choi, Y. et al. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature 346, 471–473 ( 1990). (10.1038/346471a0) / Nature by Y Choi (1990)
  9. Kappler, J. et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 244, 811– 814 (1989). (10.1126/science.2524876) / Science by J Kappler (1989)
  10. Janeway, C. A. et al. T Cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol. Rev. 107, 61– 68 (1989). (10.1111/j.1600-065X.1989.tb00003.x) / Immunol. Rev. by CA Janeway (1989)
  11. Choi, Y. et al. Interaction of Staphylococcus aureus toxin “superantigens” with human T cells. Proc. Natl. Acad. Sci. USA 86, 8941–8945 (1989). (10.1073/pnas.86.22.8941) / Proc. Natl. Acad. Sci. USA by Y Choi (1989)
  12. Marrack, P., Blackman, M., Kushnir, E. & Kappler, J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells . J. Exp. Med. 171, 455– 464 (1990). (10.1084/jem.171.2.455) / J. Exp. Med. by P Marrack (1990)
  13. Miethke, T. et al. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175, 91–98 (1992). (10.1084/jem.175.1.91) / J. Exp. Med. by T Miethke (1992)
  14. Hackett, S.P. & Stevens, D.L. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-β synthesis. J. Infect. Dis. 168, 232–235 (1993). (10.1093/infdis/168.1.232) / J. Infect. Dis. by SP Hackett (1993)
  15. Uchiyama, T. et al. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells. Clin. Exp. Immunol. 75, 239–244 (1989). / Clin. Exp. Immunol. by T Uchiyama (1989)
  16. Fiorentino, D.F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444–3451 (1991). (10.4049/jimmunol.146.10.3444) / J. Immunol. by DF Fiorentino (1991)
  17. Bean, A.G., Freiberg, R.A., Andrade, S., Menon, S. & Zlotnik, A. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61, 4937–4939 ( 1993). (10.1128/IAI.61.11.4937-4939.1993) / Infect. Immun. by AG Bean (1993)
  18. Groux, H., Bigler, M., de Vries, J.E. & Roncarolo, M.G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184, 19–29 (1996). (10.1084/jem.184.1.19) / J. Exp. Med. by H Groux (1996)
  19. Swaminathan, S., Furey, W., Pletcher, J. & Sax, M. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359, 801–805 (1992). (10.1038/359801a0) / Nature by S Swaminathan (1992)
  20. Jardetzky, T.S. et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711–718 (1994). (10.1038/368711a0) / Nature by TS Jardetzky (1994)
  21. Fields, B.A. et al. Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature 384, 188– 192 (1996). (10.1038/384188a0) / Nature by BA Fields (1996)
  22. Papageorgiou, A.C., Tranter, H.S. & Acharya, K.R. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J. Mol. Biol. 277, 61–79 (1998). (10.1006/jmbi.1997.1577) / J. Mol. Biol. by AC Papageorgiou (1998)
  23. Leder, L. et al. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and major histocompatibility complex class II. J. Exp. Med. 187, 823– 833 (1998). (10.1084/jem.187.6.823) / J. Exp. Med. by L Leder (1998)
  24. Buelow, R. et al. Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins. J. Immunol. 148, 1–6 ( 1992). (10.4049/jimmunol.148.1.1) / J. Immunol. by R Buelow (1992)
  25. Kappler, J.W., Herman, A., Clements, J. & Marrack, P. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 175, 387–389 (1992). (10.1084/jem.175.2.387) / J. Exp. Med. by JW Kappler (1992)
  26. Hoffmann, M.L. et al. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect. Immun. 62, 3396–3407 ( 1994). (10.1128/IAI.62.8.3396-3407.1994) / Infect. Immun. by ML Hoffmann (1994)
  27. Betley, M.J. & Mekalanos, J.J. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J. Bacteriol. 170 , 34–41 (1988). (10.1128/jb.170.1.34-41.1988) / J. Bacteriol. by MJ Betley (1988)
  28. Galanos, C., Freudenberg, M.A. & Reutter, W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76, 5939–5943 (1979). (10.1073/pnas.76.11.5939) / Proc. Natl. Acad. Sci. USA by C Galanos (1979)
  29. Lowell, G.H. et al. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect. Immun. 64, 1706– 1713 (1996). (10.1128/IAI.64.5.1706-1713.1996) / Infect. Immun. by GH Lowell (1996)
  30. Basma, H. et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect. Immun. 67, 1871–1877 ( 1999). (10.1128/IAI.67.4.1871-1877.1999) / Infect. Immun. by H Basma (1999)
  31. Komisar, J.L., Small-Harris, S. & Tseng, J. Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB. Infect. Immun. 62, 4775– 4780 (1994). (10.1128/IAI.62.11.4775-4780.1994) / Infect. Immun. by JL Komisar (1994)
  32. Jett, M. et al. Identification of sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect. Immun. 62, 3408–3415 (1994). (10.1128/IAI.62.8.3408-3415.1994) / Infect. Immun. by M Jett (1994)
  33. Wang, B., Schlievert, P.M., Gaber, A.O. & Kotb, M. Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J. Immunol. 151, 1419–1429 (1993). (10.4049/jimmunol.151.3.1419) / J. Immunol. by B Wang (1993)
  34. Earhart, C.A. et al. Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity. Biochemistry 37, 7194–202 (1998). (10.1021/bi9721896) / Biochemistry by CA Earhart (1998)
  35. Hudson, K.R. et al. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J. Exp. Med. 182, 711–720 (1995). (10.1084/jem.182.3.711) / J. Exp. Med. by KR Hudson (1995)
  36. Schad, E.M. et al. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J. 14, 3292– 3301 (1995). (10.1002/j.1460-2075.1995.tb07336.x) / EMBO J. by EM Schad (1995)
  37. Abrahmsen, L. et al. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J. 14, 2978–2986 (1995). (10.1002/j.1460-2075.1995.tb07300.x) / EMBO J. by L Abrahmsen (1995)
  38. Muraille, E. et al. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. Cell. Immunol. 162, 315–320 (1995). (10.1006/cimm.1995.1084) / Cell. Immunol. by E Muraille (1995)
  39. Muraille, E., De Smedt, T., Urbain. J., Moser, M. & Leo, O. B7.2 provides co-stimulatory functions in vivo in response to staphylococcal enterotoxin B. Eur. J. Immunol. 25, 2111 –2114 (1995). (10.1002/eji.1830250747) / Eur. J. Immunol. by E Muraille (1995)
  40. Saha, B. et al. Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig . J. Immunol. 157, 3869– 3875 (1996). (10.4049/jimmunol.157.9.3869) / J. Immunol. by B Saha (1996)
  41. Gerez, L., Arad, G., Efrat, S., Ketzinel, M. & Kaempfer, R. Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts. J. Biol. Chem. 270, 19569–19575 ( 1995). (10.1074/jbc.270.33.19569) / J. Biol. Chem. by L Gerez (1995)
  42. Arad, G. et al. Transient expression of human IL-2 and IFN-γ genes is regulated by interaction between distinct cell subsets. Cellular Immunol. 160, 240–247 ( 1995). (10.1016/0008-8749(95)80034-G) / Cellular Immunol. by G Arad (1995)
  43. Jarrous, N., Osman, F. & Kaempfer, R. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 16, 2814–2822 (1996). (10.1128/MCB.16.6.2814) / Mol. Cell. Biol. by N Jarrous (1996)
  44. Gerez, L. et al. Aberrant regulation of interleukin-2 but not of interferon-γ gene expression in Down Syndrome (Trisomy 21). Clin. Immunol. Immunopathol. 58, 251–266 ( 1991). (10.1016/0090-1229(91)90140-6) / Clin. Immunol. Immunopathol. by L Gerez (1991)
  45. Kaempfer, R. et al. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression. J. Clin. Oncol. 14, 1778–1786 (1996). (10.1200/JCO.1996.14.6.1778) / J. Clin. Oncol. by R Kaempfer (1996)
  46. Prasad, G.S. et al. Structure of toxic shock syndrome toxin 1. Biochemistry 32, 13761–13766 ( 1993). (10.1021/bi00213a001) / Biochemistry by GS Prasad (1993)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:34 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:13 p.m.)
Indexed 3 months, 2 weeks ago (May 22, 2025, 3:11 a.m.)
Issued 25 years, 5 months ago (April 1, 2000)
Published 25 years, 5 months ago (April 1, 2000)
Published Print 25 years, 5 months ago (April 1, 2000)
Funders 0

None

@article{Arad_2000, title={Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation}, volume={6}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/74672}, DOI={10.1038/74672}, number={4}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Arad, Gila and Levy, Revital and Hillman, Dalia and Kaempfer, Raymond}, year={2000}, month=apr, pages={414–421} }